Use of radical cystectomy for patients with invasive bladder cancer.

BACKGROUND Evidence-based guidelines recommend radical cystectomy for patients with muscle-invasive bladder cancer. However, many patients receive alternate therapies, such as chemotherapy or radiation. We examined factors that are associated with the use of radical cystectomy for invasive bladder cancer and compared the survival outcomes of patients with invasive bladder cancer by the treatment they received. METHODS From linked Surveillance, Epidemiology, and End Results-Medicare data, we identified a cohort of 3262 Medicare beneficiaries aged 66 years or older at diagnosis with stage II muscle-invasive bladder cancer from January 1, 1992, through December 31, 2002. We examined the use of radical cystectomy with multilevel multivariable models and survival after diagnosis with the use of instrumental variable analyses. All statistical tests were two-sided. RESULTS A total of 21% of the study subjects underwent radical cystectomy. Older age at diagnosis and higher comorbidity were associated with decreased odds of receiving cystectomy (for those > or = 80 vs 66-69 years old, odds ratio [OR] = 0.10, 95% confidence interval [CI] = 0.07 to 0.14; for Charlson comorbidity index of 3 vs 0-1, OR = 0.25, 95% CI = 0.14 to 0.45). Long travel distance to an available surgeon was associated with decreased odds of receiving cystectomy (for >50 vs 0-4 miles travel distance to an available surgeon, OR = 0.60, 95% CI = 0.37 to 0.98). Overall survival was better for those who underwent cystectomy compared with those who underwent alternative treatments (for chemotherapy and/or radiation vs cystectomy, hazard ratio of death = 1.5, 95% CI = 1.3 to 1.8; for surveillance vs cystectomy, hazard ratio of death = 1.9, 95% CI = 1.6 to 2.3; 5-year adjusted survival: 42.2% [95% CI = 39.1% to 45.4%] for cystectomy; 20.7% [95% CI = 18.7% to 22.8%] for chemotherapy and/or radiation; 14.5% [95% CI = 13.0% to 16.2%] for surveillance). CONCLUSIONS Guideline-recommended care with radical cystectomy is underused for patients with muscle-invasive bladder cancer. Many bladder cancer patients whose survival outcomes might benefit with surgery are receiving alternative less salubrious treatments.

[1]  G. Green,et al.  Health care utilization and the proportion of primary care physicians. , 2008, The American journal of medicine.

[2]  A. Jemal,et al.  Cancer Statistics, 2005 , 2005, CA: a cancer journal for clinicians.

[3]  Elliott S Fisher,et al.  Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods. , 2007, JAMA.

[4]  J. Birkmeyer,et al.  Hospital volume and surgical mortality in the United States. , 2002, The New England journal of medicine.

[5]  G. Anderson,et al.  The Growing Burden of Chronic Disease in America , 2004, Public health reports.

[6]  John T. Wei,et al.  The regionalization of radical cystectomy to specific medical centers. , 2005, The Journal of urology.

[7]  C. Ko,et al.  Continuity of care: Readmission to the same hospital following gastric cancer resection , 2009 .

[8]  A. Murtha,et al.  Muscle-invasive transitional cell carcinoma of the urinary bladder: a population-based study of patterns of care and prognostic factors. , 2001, International journal of radiation oncology, biology, physics.

[9]  J. Newhouse,et al.  Econometrics in outcomes research: the use of instrumental variables. , 1998, Annual review of public health.

[10]  Andrew P. Jones,et al.  Validation of travel times to hospital estimated by GIS , 2006, International journal of health geographics.

[11]  B. Konety,et al.  Impact of hospital and surgeon volume on in-hospital mortality from radical cystectomy: data from the health care utilization project. , 2005, The Journal of urology.

[12]  Paul J Rathouz,et al.  Two-stage residual inclusion estimation: addressing endogeneity in health econometric modeling. , 2008, Journal of health economics.

[13]  A Pollack,et al.  NCCN urothelial cancer practice guidelines. National Comprehensive Cancer Network. , 1998, Oncology.

[14]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[15]  T. Ricketts,et al.  Rural breast cancer treatment: evidence from the Reaching Communities for Cancer Care (REACH) project , 1999, Breast Cancer Research and Treatment.

[16]  E. Demidenko,et al.  Geographic access to cancer care in the U.S. , 2008, Cancer.

[17]  C. Roehrborn,et al.  The value of your time: evaluation of effects of changes in medicare reimbursement rates on the practice of urology. , 2004, The Journal of urology.

[18]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[19]  D. Forman,et al.  A study of the morbidity, mortality and long-term survival following radical cystectomy and radical radiotherapy in the treatment of invasive bladder cancer in Yorkshire. , 2003, European urology.

[20]  W. Mcdougal,et al.  Use of Intestinal Segments in Urinary Diversion , 2012 .

[21]  D. Forman,et al.  Travel time to hospital and treatment for breast, colon, rectum, lung, ovary and prostate cancer. , 2008, European journal of cancer.

[22]  J L Freeman,et al.  Associations among hospital capacity, utilization, and mortality of US Medicare beneficiaries, controlling for sociodemographic factors. , 2000, Health services research.

[23]  J. Richie,et al.  Bladder cancer. Clinical guidelines in oncology. , 2006, Journal of the National Comprehensive Cancer Network : JNCCN.

[24]  A. Gittelsohn,et al.  Small Area Variations in Health Care Delivery , 1973, Science.

[25]  J. Montie.  Radical cystectomy in the elderly: comparison of survival between younger and older patients. , 2005, The Journal of urology.

[26]  L. Kessler,et al.  Potential for Cancer Related Health Services Research Using a Linked Medicare‐Tumor Registry Database , 1993, Medical care.

[27]  David R. Williams,et al.  Measuring social class in US public health research: concepts, methodologies, and guidelines. , 1997, Annual review of public health.

[28]  J. Birkmeyer,et al.  Volume, process of care, and operative mortality for cystectomy for bladder cancer. , 2007, Urology.

[29]  Craig Duncan,et al.  Multilevel methods for public health research , 2000 .

[30]  R F Nease,et al.  Patient preferences for location of care: implications for regionalization. , 1999, Medical care.

[31]  Jeffrey M. Wooldridge,et al.  Introductory Econometrics: A Modern Approach , 1999 .

[32]  David Forman,et al.  A 10-year retrospective review of a nonrandomized cohort of 458 patients undergoing radical radiotherapy or cystectomy in Yorkshire, UK. , 2010, International journal of radiation oncology, biology, physics.

[33]  B. Konety,et al.  Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program. , 2003, The Journal of urology.

[34]  James M. Kozlowski,et al.  NCCN Urothelial Cancer Practice Guidelines , 1998 .

[35]  D. Goodman,et al.  Access to cancer services for rural colorectal cancer patients. , 2008, The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association.

[36]  A. Jemal,et al.  Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.

[37]  John T. Wei,et al.  Measuring health‐related quality of life outcomes in bladder cancer patients using the Bladder Cancer Index (BCI) , 2007, Cancer.

[38]  N. Krieger.  Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. , 1992, American journal of public health.

[39]  A. D. Diez Roux,et al.  Neighborhoods and health , 2010, Annals of the New York Academy of Sciences.

[40]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[41]  Roel Bosker,et al.  Multilevel analysis : an introduction to basic and advanced multilevel modeling , 1999 .

[42]  W J Mackillop,et al.  The management and outcome of bladder carcinoma in Ontario, 1982–1994 , 2000, Cancer.

[43]  A. Wein,et al.  Campbell-Walsh Urology , 2011 .

[44]  Christopher S Saigal,et al.  Diffusion of surgical innovation among patients with kidney cancer , 2008, Cancer.

[45]  Moore Fd.  Small area variations in health care delivery. A critique. , 1977, The Journal of the Maine Medical Association.

[46]  M. Casey,et al.  Do Rural Elders Have Limited Access to Medicare Hospice Services? , 2004, Journal of the American Geriatrics Society.

[47]  John T. Wei,et al.  Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80 years old or older. , 2004, Urology.

[48]  S. Groshen,et al.  Radical cystectomy in the elderly , 2005, Cancer.

[49]  Andrea Erickson Best,et al.  Secondary Data Bases and Their Use in Outcomes Research: A Review of the Area Resource File and the Healthcare Cost and Utilization Project , 1999, Journal of Medical Systems.

[50]  J. Terza,et al.  The use of linear instrumental variables methods in health services research and health economics: a cautionary note. , 2007, Health services research.

[51]  William A Knaus,et al.  Impact of patient distance to radiation therapy on mastectomy use in early-stage breast cancer patients. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.